SIU Medicine will continue COVID-19 testing for the Springfield community in March. On Mondays, Tuesdays and Thursdays, the testing operation will be hosted by Abundant Faith Christian Center located at 2525 Taylor Ave. Mondays: 9 – 11 a.m. and 1 – 4 p.m. Tuesdays: 9 – 11 a.m. and 1 – 4 p.m. Thursdays: 9 – 11 a.m. and 1 – 4 p.m. Additional testing is conducted on Fridays, hosted by other area congregations. March 5, 9 a.m. - noon at Second Timothy Baptist Church, 1122 E. Pine Street March 12, 9 a.m. - noon at Westminster Presbyterian Church, 533 S. Walnut Street March 19, 9 a.m. - noon at

Freedom of Information Act (FOIA) requests The Office of General Counsel is responsible for addressing FOIA requests in a timely manner. FOIA requests should be submitted in writing. Mail, email, or fax requests to the FOIA officer: FOIA Officer SIU School of Medicine 201 E. Madison Street, Suite 104 Springfield, IL 62794-9619 217-545-2427 (Fax) FOIA@siumed.edu Media inquiries The Office of Marketing, Communications and Engagement is dedicated to sharing the newsworthy developments at SIU Medicine, the brand name for both SIU School of Medicine and its multi-specialty clinical practice. We

General inquiry | Request information SIU Medicine Doctor of Medical Science Southern Illinois University 300 West Oak St Mail Code 6516 Carbondale, IL 62901 Telephone:618-453-5528 Email: DMSc@siu.edu Jacob Ribbing, DMSc, PA-C Director of Doctoral Education Assistant Professor jribbing38@siumed.edu 618-453-2664 Staci Eakins, BS Administrative Assistant Doctoral Education seakins76@siumed.edu 618-453-5528

1. Educate physician assistants to be lifelong learners, proficient in acquiring and applying knowledge to improve the health of their communities and organizations. 2. Prepare physician assistants to be respectful, ethical, professional and effective advocates for the profession and their patients. 3. Prepare physician assistants who are competitive, marketable, and competent to take on administrative and leadership roles within the health care arena and beyond. 4. Prepare physician assistants to become proficient, competent educators of the public, their patients and future PAs with a

A partial list of our notable accomplishments and innovations. SIU School of Medicine was the first institution to incorporate problem-based learning and standardized patients into its medical school curriculum. We were the first medical school in the U.S. to require a clinical competency examination before graduation. The exam is now a model for physician licensure throughout the country. The Professional Development Laboratory allows evaluation of students in standardized and real patient encounters in a precise replica of an exam room. It was the first such facility in the nation, providing

In 1968, the Illinois Board of Higher Education sparked the creation of something necessary and bold: Its members recommended that Southern Illinois University establish a medical school. Placing the clinical education programs of the new school in Springfield and basic science programs in Carbondale would make use of the educational resources already available on the downstate campus and the established health care networks in the State Capital. Primary care for downstate Illinois Under the direction of the founding dean, Dr. Richard H. Moy, SIU School of Medicine was established in 1970 with

SIU Medicine will continue COVID-19 testing for the Springfield community in February. On Mondays, Tuesdays and Thursdays, the testing operation will be hosted by Abundant Faith Christian Center located at 2525 Taylor Ave. Mondays: 9 – 11 a.m. and 1 – 4 p.m. Tuesdays: 9 – 11 a.m. and 1 – 4 p.m. Thursdays: 9 – 11 a.m. and 1 – 4 p.m. Fridays: 1 – 4 p.m. (at Abundant Faith Christian Center, 301 West Reynolds Campus) Additional testing is conducted on Fridays, hosted by other area congregations. February 5, 9 a.m. - noon at Monroe Street Christian Church, 1229 E. Monroe St. February 12, 9 a.m. -

2021 Memorial Medical Center Foundation Grant Application

Riluzole is an FDA-approved drug, currently used to treat amyotrophic lateral sclerosis (ALS; Lou Gehrig's disease) and is currently in a Phase II clinical trial for the treatment of mild Alzheimer’s disease (AD) (Clinical Trial #NCT01703117). The exact reason behind riluzole’s potential benefits on cognition in AD patients is unknown. One potential way may be through altering glutamate signaling in the brain, a neurotransmitter essential for learning and memory. A team of researchers at the Center for Alzheimer’s Disease and Related Disorders at SIU Medicine lead by Kevin N. Hascup, PhD, and